Kim, S. C., Solomon, D. H., Rogers, J. R., Gale, S., Klearman, M., Sarsour, K., & Schneeweiss, S. (2017). Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study. Arthritis Rheumatol.

Kim, Seoyoung C., Daniel H. Solomon, James R. Rogers, Sara Gale, Micki Klearman, Khaled Sarsour, och Sebastian Schneeweiss. "Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study." Arthritis Rheumatol 2017.

Kim, Seoyoung C., et al. "Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi‐Database Cohort Study." Arthritis Rheumatol 2017.